Clinical Trial

A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma

Name: A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma — clinical trial record (NCT07014540)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

To explore the efficacy and safety of irinotecan liposome injection combined with 5-FU/LV in the treatment of advanced neuroendocrine carcinoma (NEC)

Trial Details

NCT Number	NCT07014540
Lead Sponsor	Beijing GoBroad Hospital Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions	Neuroendocrine Carcinomas (NEC)
Enrollment	45 participants
Start Date	2025-06-20
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-06-11